I have been the lead investigator for my local hospital when my team participated in the pan-European research trial of Coloplast Silver Contreet Foam versus standard wound care. This was an international comparative, randomized, multi-national evaluation on clinical- and cost-effectiveness of an antibacterial foam dressing. The project aim was to reduce relative ulcer healing time during the treatment period and to study wound bed preparation in terms of reduction in odour and exudate levels as well as tissue composition. Cost-effectiveness was based on the number of dressing changes, and nursing time costs associated with treatment of infection. Health-related quality of life was based on odour, leakage, pain and overall health status.
I therefore can offer: